360 related articles for article (PubMed ID: 31838579)
41. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
Jesinghaus M; Schmitt M; Lang C; Reiser M; Scheiter A; Konukiewitz B; Steiger K; Silva M; Tschurtschenthaler M; Lange S; Foersch S; Becker KF; Saur D; Friess H; Halfter K; Engel J; Boxberg M; Pfarr N; Wilhelm D; Weichert W
Am J Surg Pathol; 2021 Jul; 45(7):969-978. PubMed ID: 34105518
[TBL] [Abstract][Full Text] [Related]
42. Association of tumor budding with clinicopathological features and prognostic value in stage III-IV colorectal cancer.
Luo YH; Yan ZC; Liu JY; Li XY; Yang M; Fan J; Huang B; Ma CG; Chang XN; Nie X
World J Gastroenterol; 2024 Jan; 30(2):158-169. PubMed ID: 38312121
[TBL] [Abstract][Full Text] [Related]
43. Predictive power of tumour budding for lymph node metastasis in colorectal carcinomas: A retrospective study.
Deb B; Jacob SE
Indian J Med Res; 2019 Dec; 150(6):635-639. PubMed ID: 32048628
[TBL] [Abstract][Full Text] [Related]
44. The relationship between tumor budding and survival in colorectal carcinomas.
Ozer SP; Barut SG; Ozer B; Catal O; Sit M
Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1442-1447. PubMed ID: 31994623
[TBL] [Abstract][Full Text] [Related]
45. Lymphovascular infiltration in the tumor bed is a useful marker of biological behavior in breast cancer.
Panagiotopoulos N; Lagoudianakis E; Pappas A; Filis K; Salemis N; Manouras A; Kontzoglou K; Zografos G
J BUON; 2016; 21(5):1082-1089. PubMed ID: 27837608
[TBL] [Abstract][Full Text] [Related]
46. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
Johncilla M; Chen Z; Sweeney J; Yantiss RK
Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
[TBL] [Abstract][Full Text] [Related]
47. Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
Oh BY; Park YA; Huh JW; Yun SH; Kim HC; Chun HK; Kim SH; Ha SY; Lee WY; Cho YB
Ann Surg Oncol; 2018 Jan; 25(1):204-211. PubMed ID: 29086140
[TBL] [Abstract][Full Text] [Related]
48. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
49. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
50. Adverse Histologic Features in Colorectal Nonpedunculated Malignant Polyps With Nodal Metastasis.
Patel N; Vyas M; Celli R; Jain D; Zhang X
Am J Surg Pathol; 2020 Feb; 44(2):241-246. PubMed ID: 31498179
[TBL] [Abstract][Full Text] [Related]
51. Tumoral and Parenchymal Morphological Assessment in Liver Metastases of Colorectal Carcinoma: Micrometastasis, Peritumoral Lymphocytes, Tumor Budding and Differentiation are Potential Prognostic Factors.
Aysal A; Agalar C; Egeli T; Ozbilgin M; Unek T; Somali I; Oztop I; Obuz F; Astarcioglu I; Sagol O
Int J Surg Pathol; 2022 Dec; 30(8):861-871. PubMed ID: 35491669
[No Abstract] [Full Text] [Related]
52. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
Weis CA; Kather JN; Melchers S; Al-Ahmdi H; Pollheimer MJ; Langner C; Gaiser T
Diagn Pathol; 2018 Aug; 13(1):64. PubMed ID: 30153844
[TBL] [Abstract][Full Text] [Related]
53. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting.
Betge J; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Vieth M; Hoefler G; Langner C
Cancer; 2012 Feb; 118(3):628-38. PubMed ID: 21751188
[TBL] [Abstract][Full Text] [Related]
54. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of lymphovascular space invasion in low-risk endometrial cancer.
Ayhan A; Şahin H; Sari ME; Yalçin I; Haberal A; Meydanli MM
Int J Gynecol Cancer; 2019 Mar; 29(3):505-512. PubMed ID: 30665899
[TBL] [Abstract][Full Text] [Related]
56. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
[TBL] [Abstract][Full Text] [Related]
57. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
[TBL] [Abstract][Full Text] [Related]
58. Expression of phospho-mTOR kinase is abundant in colorectal cancer and associated with left-sided tumor localization.
Melling N; Simon R; Izbicki JR; Terracciano LM; Bokemeyer C; Sauter G; Marx AH
Int J Clin Exp Pathol; 2015; 8(6):7009-15. PubMed ID: 26261591
[TBL] [Abstract][Full Text] [Related]
59. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
[TBL] [Abstract][Full Text] [Related]
60. A novel ability of endocytoscopy to diagnose histological grade of differentiation in T1 colorectal carcinomas.
Sako T; Kudo SE; Miyachi H; Wakamura K; Igarashi K; Misawa M; Mori Y; Kudo T; Hayashi T; Katagiri A; Ishida F; Azuma T; Inoue H; Hamatani S
Endoscopy; 2018 Jan; 50(1):69-74. PubMed ID: 28962043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
